title: International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update.
abstract: Previous publications have described the International Dermatology Outcome Measures (IDEOM) group, comprising patients, physicians, health economists, participating pharmaceutical industry partners, payers, and regulatory agencies. The goal of IDEOM is to create patient-centered, validated measures of dermatologic disease progression and treatment efficacy for use in both clinical trials and clinical practice. We provide an update of IDEOM activities as of our 2015 IDEOM meeting in Washington, DC, USA.
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center. jfmerola@bwh.harvard.edu.
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Merola
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.
authors.forename: April W
authors.initials: AW
authors.lastname: Armstrong
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.
authors.forename: Ami
authors.initials: A
authors.lastname: Saraiya
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.
authors.forename: John
authors.initials: J
authors.lastname: Latella
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.
authors.forename: Amit
authors.initials: A
authors.lastname: Garg
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.
authors.forename: Kristina
authors.initials: K
authors.lastname: Callis Duffin
authors.affiliation: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; University of Southern California, Los Angeles, California; Tufts Medical Center, Boston, Massachusetts; Hofstra North Shore LIJ School of Medicine, Manhasset, New York; University of Utah, Salt Lake City, Utah, USA.J.F. Merola, MD, MMSc, Brigham and Women's Hospital, Harvard Medical School; A.W. Armstrong, MD, University of Southern California; A. Saraiya, Tufts Medical Center; J. Latella, International Dermatology Outcome Measures (IDEOM) Patient Research Partner and IDEOM Board of Directors, West Granby, Connecticut, USA; A. Garg, MD, Hofstra North Shore LIJ School of Medicine; K. Callis Duffin, MD, University of Utah; A.B. Gottlieb, MD, PhD, Tufts Medical Center.
authors.forename: Alice B
authors.initials: AB
authors.lastname: Gottlieb
mesh_terms: D015535:Arthritis, Psoriatic / Q000628:therapy*; D003880:Dermatology; D006801:Humans; D017063:Outcome Assessment, Health Care; D016896:Treatment Outcome
keywords: IDEOM; OMERACT; OUTCOME MEASURES; PSORIASIS